Report Scope & Overview:
The Remote Patient Monitoring (RPM) Market Size was valued at USD 51.4 billion in 2022, and expected to reach USD 354.49 billion by 2030, and grow at a CAGR of 27.3% over the forecast period 2023-2030.
Remote patient monitoring (RPM) is a type of homecare telehealth which allows people to collect and communicate patient-generated health data (PGHD) to healthcare experts via mobile medical equipment and technology. Vital signs, weight, blood pressure, and heart rate are just a few of the physiological data that RPM programmes can collect. Patient information is collected and transferred to a doctor's office via a telehealth computer system or software application that can be placed on a computer, smartphone, or tablet. RPM is normally used to help patients who require long haul, post-release, or geriatric consideration. It can inform healthcare companies of potential health risks or keep track of patient data between visits by linking high-risk patients with remote monitoring. Furthermore, organisations who want to track workmen's compensation cases could utilised RPM to ensure that employees are on the right track to return to work.
MARKET DYNAMICS
DRIVERS
Increasing senior population necessitates expanding healthcare access.
The need for home-based monitoring devices is increasing.
Advancement of technology
RESTRAINTS
Professionals in the healthcare field are resisting.
Regulatory Environment that Is tough.
Reimbursement that isn't up to the mark.
OPPORTUNITIES
RPM has a wide range of applications in the fight against infectious illnesses and epidemics.
CHALLENGES
Behavioral hurdles, healthcare accessibility, and unawareness are all issues that need to be addressed.
IMPACT OF COVID-19
The COVID-19 episode essentially affects the growth elements of different on the medical services ventures owed to its immense monetary effect on significant nations of the globe. As of 31st December 2021, 290 million cases have been accounted for around the world, with 5,419,881 passings (Worldometer). There has been a lift in adoption distant patient checking administrations during the COVID-19 pandemic. This positive effect is supposed to follow all through the figure period. Different new businesses immediately jumping all over the chance to satisfy the need hole of the medical care suppliers attempting to screen patients from a distance. In accordance with this, distant patient observing addresses an alluring, viable, and reasonable choice. Additionally, this innovation is of basic significance in protecting medical services suppliers.
Segmentation Analysis of By End Use
The clinic-based patient portion was the main end-use section in 2021 and represented 79.4% of the income share. Emergency clinics take special care of an enormous number of short-term patients as well as inpatients. They offer an enormous number of demonstrative tests and have a bigger specialized staff for taking care of the necessities of the patients. An enormous patient pool and a rising number of tests being performed are the indispensable drivers for portion development. Clinic patients are owned up to offices needing intense consideration and subsequently keeping a consistent beware of the imperative boundaries of patients is crucial. Nonetheless, the significant expense of medical clinic confirmations and dreary repayment techniques are supposed to limit the market development.
COMPETITIVE LANDSCAPE
Some of the major key players are as follows: Abbott, Boston Scientific Corporation, F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Nihon Kohden Corporation, Omron Corporation, Smiths Medical, OSI Systems, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Welch Allyn, and other players.
MARKET SEGMENTATION:
By Component:
Services & Software
Devices
Cardiac Monitoring Devices
Neurological Monitoring Devices
Respiratory Monitoring Devices
Blood Glucose Monitoring Devices
Weight Monitoring Devices
Multiparameter Monitoring Devices
Fetal &Neonatal Monitoring Devices
Others
By End-Use:
Providers
Hospitals & Clinics
Passive Exoskeletons
Ambulatory Care Centers
Home Care Settings & Long-term Care Centers
Others
Payers
Patients
Other End-Users
REGIONAL ANALYSIS
The central point driving the far off persistent observing business sector size development incorporate the developing weight of ongoing infections, expanding geriatric populace, interest for remote and versatile frameworks, and the presence of a modern repayment structure.
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
| Report Attributes | Details |
|---|---|
| Market Size in 2022 | US$ 51.4 Billion |
| Market Size by 2030 | US$ 354.47 Billion |
| CAGR | CAGR of 27.3% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments |
|
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Abbott, Boston Scientific Corporation, F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Nihon Kohden Corporation, Omron Corporation, Smiths Medical, OSI Systems, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Welch Allyn, and other players. |
| DRIVERS | • Increasing senior population necessitates expanding healthcare access. • The need for home-based monitoring devices is increasing. • Advancement of technology |
| RESTRAINTS | • Professionals in the healthcare field are resisting. • Regulatory Environment That Is Tough • Reimbursement that isn't up to par |
Top-down, bottom-up, Quantitative, Qualitative Research, Descriptive, Analytical, Applied, Fundamental Research.
The challenges faced by Remote Patient Monitoring (RPM) is Behavioral hurdles, healthcare accessibility, and unawareness are all issues that need to be addressed.
The by Application is divided into ten sub segments is Bronchitis Cancer, Diabetes, Cardiovascular Diseases, Infections, Dehydration, Sleep Disorder, Weight management and Fitness Monitoring, Hypertension, and Virus.
Remote Patient Monitoring industry, North America overwhelmed the worldwide market.
Remote Patient Monitoring (RPM) Market is expected to reach USD 4.620 billion by 2028.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Remote Patient Monitoring (RPM) Market Segment, By Component
8.1 Services & Software
8.2 Devices
8.2.1 Cardiac Monitoring Devices
8.2.2 Neurological Monitoring Devices
8.2.3 Respiratory Monitoring Devices
8.2.4 Blood Glucose Monitoring Devices
8.2.5 Weight Monitoring Devices
8.2.6 Multiparameter Monitoring Devices
8.2.7 Fetal &Neonatal Monitoring Devices
8.2.8 Others
9. Remote Patient Monitoring (RPM) Market Segment, By End-Use
9.1 Providers
9.1.1 Hospitals & Clinics
9.1.2 Passive Exoskeletons
9.1.3 Ambulatory Care Centers
9.1.4 Home Care Settings & Long-term Care Centers
9.1.5 Others
9.2 Payers
9.3 Patients
9.4 Other End-Users
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 USA
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 The Netherlands
10.3.7 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 South Korea
10.4.3 China
10.4.4 India
10.4.5 Australia
10.4.6 Rest of Asia-Pacific
10.5 The Middle East & Africa
10.5.1 Israel
10.5.2 UAE
10.5.3 South Africa
10.5.4 Rest
10.6 Latin America
10.6.1 Brazil
10.6.2 Argentina
10.6.3 Rest of Latin America
11. Company Profiles
11.1 Abbott
11.1.1 Financial
11.1.2 Products/ Services Offered
11.1.3 SWOT Analysis
11.1.4 The SNS view
11.2 Boston Scientific Corporation
11.3 F. Hoffmann-La Roche Ltd
11.4 Koninklijke Philips N.V.
11.5 Nihon Kohden Corporation
11.6 Omron Corporation
11.7 Smiths Medical
11.8 OSI Systems, Inc.
11.9 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
11.10 Welch Allyn
12. Competitive Landscape
12.1 Competitive Benchmark
12.2 Market Share analysis
12.3 Recent Developments
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Report Scope & Overview: Type 1 Diabetes Market Size was value
Report Scope & Overview:
The Molecular Modeling Market Size was valued at USD 7.07 billion in 2022 and is expected to reach USD 19.90 billion by 2030, and grow at a CAGR of 13.8% over the forecast period 2023-2030.
The Cognitive Behavioral Therapy Market size was valued at USD 159.21 billion in 2022 and is expected to reach at USD 294.01 billion by 2030, and grow at a CAGR of 8.2% over the forecast period of 2023-2030.
Report Scope & Overview: Healthcare CRM Market
The Fill-Finish Manufacturing Market Size was valued at USD 9.44 billion in 2022 and is expected to reach USD 20.39 billion by 2030, and grow at a CAGR of 10.1% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2023 All Rights Reserved by SNS Insider Pvt Ltd
